Navigation Links
SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)
Date:2/26/2008

New Products for Medical Professionals, Hospital and Managed Care

Facilities

NEW YORK, February 26 /PRNewswire-FirstCall/ -- SPO Medical Inc. (SPOM)( http://finance.yahoo.com/q?s=SPOM.OB), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, today announced its first commercial shipments of its recently announced professional pulse oximeters; the PulseOx 6000(TM) and PulseOx 6100(TM).

At the end of the fourth quarter 2007, SPO Medical introduced these two new professional products at the 53rd Annual International Respiratory Congress of the American Association for Respiratory Care (AARC) in Orlando, Florida and at the 39th MEDICA World Forum for Medicine in Dusseldorf, Germany.

The PulseOx 6000(TM) (finger device) and PulseOx 6100(TM) (hand-held device) are both designed for medical professionals, hospitals and managed care facilities. Based on SPO Medical' proprietary patented algorithms, both the PulseOx 6000(TM) and PulseOx 6100(TM) use Reflective Pulse Oximetry (RPO) technology for accurate and reliable measurements of blood oxygen saturation and heart rate. In addition, these devices utilize the new SPO Medical AutoSpot(TM) technology for accurate measurements even with patients that suffer from low perfusion.

SPO Medical's focus for these products is the professional medical market. Since the announcement of these new products, an order backlog has been building in the Company's major markets, the United States and European countries. Within the United States, SPO Medical will be targeting Hospital GPO's (General Purchasing Organizations) which service thousands of hospital establishments. In addition, the Company will be targeting large medical equipment distributors which service Outpatient Surgery Centers, Integrated Healthcare Delivery Networks and Federal Government facilities.

"Three months ago, we announced the PulseOx 6000(TM) and PulseOx 6100(TM) products; since then, orders have been building in all our major markets," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "This marks SPO Medical's first entree into the professional healthcare market, after developing a solid reputation over the last three years in the homecare market. These new products further demonstrate our long-term strategy of adapting SPO Medical's patented technology platform to new applications, which provide healthcare service providers and consumers with cost-effective life-enhancing information."

About SPO Medical

SPO Medical (SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit http://www.spomedical.com.

Safe Harbor:

This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, changes in economic conditions generally and the medical devices market specifically, changes in technology, legislative or regulatory changes that affect us, the availability of working capital, the introduction of competing products, market acceptance of our new products, changes in our operating strategy or development plans and the risks and uncertainties discussed under the heading "Risk Factors" in Item 1 of our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006. We undertake no obligation to revise or update any forward-looking statement for any reason.

SPO Medical Contact:

Michael Braunold, President & CEO

info@spomedical.com

+1-805-823-8163

Target 3 Communications Contact:

Jerry Cahn, Ph.D., J.D., President

jerry@target3.com

+1-646-827-0009


'/>"/>
SOURCE SPO Medical equipment Inc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference
2. CIGNA Medical Group Selects Allscripts for Electronic Health Record
3. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
4. B-Line Medical and Immersion Medical Announce Partnership
5. MIT researcher addresses biomedical engineering challenges
6. Eklin Medical Reports Record Revenues for 2007
7. Hayes Clinical Labs to Market MedeFiles Proprietary Electronic Medical Record Management Solution to Patients
8. Symmetry Medical Reports Preliminary Fourth Quarter Revenue
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
11. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle Plating System ... designed to address fractures of the distal tibia and fibula. This system marks ... Plating System 3 is composed of seven plate families that span the lateral, ...
(Date:5/25/2016)... ... 2016 , ... The American Medical Informatics Association (AMIA) responded ... Coordinator for Health IT (ONC) outlining a measurement approach to interoperability that focuses ... and where it was needed. The organization of health informatics professionals said a ...
(Date:5/25/2016)... ... 25, 2016 , ... WEDI, the nation’s leading authority on the use of ... Stellar has been named by the WEDI Board of Directors as WEDI’s president and ... leader with more than 35 years of experience in healthcare, association management and organizational ...
(Date:5/25/2016)... ... 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) ... company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar Ataxia ... , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is estimated ...
Breaking Biology Technology:
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
(Date:3/11/2016)... March 11, 2016 --> ... research report "Image Recognition Market by Technology (Pattern Recognition), ... Advertising), by Deployment Type (On-Premises and Cloud), by Industry ... published by MarketsandMarkets, the global market is expected to ... 29.98 Billion by 2020, at a CAGR of 19.1%. ...
Breaking Biology News(10 mins):